Strata Skin Sciences ( (SSKN) ) has shared an announcement.
STRATA Skin Sciences reported a slight dip in third-quarter 2024 revenue to $8.8 million, reflecting a modest 1% decrease from the previous year. However, the company achieved its first non-GAAP operating profit since 2018, driven by strategic cost reductions and increased revenue per XTRAC system, showcasing a turnaround in business stability. STRATA also strengthened its market presence through a $2.1 million equity raise and expanded its TheraClear device placements, signaling a positive trajectory towards profitability and sustainable growth.
Find detailed analytics on SSKN stock on TipRanks’ Stock Analysis page.
